Diamonds and Dogs
Sarepta Therapeutics (SRPT) jumping 25% thanks to better than expected earnings. The company beat estimates by 32 cents while revenue of $35.01 million blew past estimates of $22.52 million thanks to strong sales of their Duchenne muscular dystrophy (DMD) therapy, Exondys 51. Several upgrades for Sarepta with price targets of $64, $56, and $33 a share.
Amazon is now hitting the home retailers. Home Depot (HD) is down 4% and Lowes (LOW) is down 5% on news Sears (SHLD) will offer Kenmore products on Amazon.com. Once again when Amazon is mentioned in a new retail category, the stocks get hit. The sell offs are hopefully getting overdone.